Innovation

Photo
07.12.2022 • NewsInnovation

Chemistry and the „Next Normal”

Numerous crises such as climate change, energy shortages, raw material shortages, war in Ukraine and the consequences of the pandemic are putting value chains worldwide to the test.

Photo
26.09.2022 • TopicsInnovation

Expert Statement: Shawn Walker, Veranova

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Photo
26.09.2022 • TopicsInnovation

Expert Statement: Kai Rossen, Euroapi

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Photo
16.05.2022 • TopicsInnovation

Nanoparticle Engineering

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.

Photo
16.09.2021 • NewsInnovation

Redesigning Tomorrow’s Plastics Today

B4Plastics is a Belgium-based biotechnology start-up and a polymer architecture company looking to catalyze the introduction of novel biomaterials and growing them from niche to bulk applications.

Photo
26.05.2021 • NewsInnovation

Rethinking the Base Material Side

Plafco Fibertech, founded in 2017, was created as a spin-off from an EU-research project coordinated by Jukka Valkama, a professor at the Cooperative State University of Baden Wurttemberg in Karlsruhe, Germany.

Photo
16.04.2021 • TopicsInnovation

Vaccine Filling at the Highest Level

Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been little involved in the production of vaccines. This is changing with the outbreak of the Covid-19 pandemic.

Photo
18.03.2021 • NewsInnovation

New Ammonia Synthesis Technology

Tsubame BHB was established in April of 2017 based on a new catalyst technology developed by Prof. em. Hideo Hosono at the ­Tokyo Institute of Technology (Tokyo Tech), which allows an ammonia process at lower temperature and pressure.

Photo
17.09.2020 • TopicsInnovation

Accelerated Drug Discovery

In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.

53 more articles

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.